Project information
Telomerase activity as a novel prognostic factor in multiple myeloma

Project Identification
Project Period
1/2002 - 12/2004
Investor / Pogramme / Project type
Ministry of Health of the CR
MU Faculty or unit
Faculty of Medicine
multiple myeloma;prognostic factors;telomerase
Cooperating Organization
Institute of Biophysics
University Hospital Brno-Bohunice

Telomerase assay in multiple myeloma is new perspective prognostic factor in multiple myeloma The use od hTERT as tumor antigen is promising new treatment modality and could circumvent limitation of current vaccination protocols in multiple myeloma in which low immunogenic antigens and consequently minimal responses are reported.


Total number of publications: 4

You are running an old browser version. We recommend updating your browser to its latest version.

More info